Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diphenylurea. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102675018B details high-purity deuterated diphenylurea synthesis. Offers cost reduction in API manufacturing and enhanced supply chain reliability for kinase inhibitors.
Patent CN1286804C details a safer triphosgene route for 4,4'-dinitrodiphenylurea, offering high purity and simplified processing for reliable pharmaceutical intermediate supply chains.
Patent CN101219972A details a non-phosgene route for symmetrical aryl urea using SeO2. Offers safer, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN101054351B enables solvent-free phenylcarbamate production. Reduces energy consumption and simplifies separation for reliable supply chain partners.